Jeffrey Farrow - Sep 27, 2022 Form 4 Insider Report for Global Blood Therapeutics, Inc. (GBT)

Role
Chief Financial Officer
Signature
/s/ Miguel Carrillo, Attorney-in-Fact
Stock symbol
GBT
Transactions as of
Sep 27, 2022
Transactions value $
$387,909
Form type
4
Date filed
9/29/2022, 08:48 PM
Previous filing
Sep 6, 2022
Next filing
Oct 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBT Common Stock Options Exercise $388K +23.7K +766.46% $16.40* 26.7K Sep 27, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBT Stock Option (Right to Buy) Options Exercise $0 -23.7K -69.67% $0.00 10.3K Sep 27, 2022 Common Stock 23.7K $16.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Common Stock underlying the option vested in equal quarterly installments over 16 quarters from January 17, 2017 through January 17, 2021.